Aquestive Therapeutics, Inc. (AQST) › Weighted Average Diluted SharesAquestive Therapeutics, Inc. (AQST) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2020-12-31: 33.65M2021-12-31: 38.08M2022-12-31: 48.73M2023-12-31: 61.26M2024-12-31: 86.73M2025-12-31: 106.93M106.93M2020-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31106.93M+23.3%2026-03-04From 2025-01-012024-12-3186.73M+41.6%2026-03-04From 2024-01-012023-12-3161.26M+25.7%2025-03-05From 2023-01-012022-12-3148.73M+28.0%2024-03-05From 2022-01-012021-12-3138.08M+13.2%2023-03-31From 2021-01-012020-12-3133.65M—2022-03-08From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)